MedTrace Logo

Performance and Safety of Restylane Lidocaine for Treatment of Depressed Facial Acne Scars

NCT03127384 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2022-08-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate performance and safety of Restylane Lidocaine for treatment of depressed facial acne scars

Conditions

  • Healthy Volunteers

Interventions

DEVICE

Restylane Lidocaine

Hyaluronic acid based filler

OTHER

No-treatment control

No-treatment control

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Study Director · Galderma R&D

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-20
Primary Completion
2018-02-15
Completion
2018-11-08

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03127384 on ClinicalTrials.gov